Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

SLC10A1 deficiency has been associated with familial hypercholanemia, or elevated concentrations of bile acids, which can lead to fat malabsorption and vitamin D deficiencies among other secondary health conditions (Vaz et al., 2015; Deng et al., 2016; Liu et al., 2017).

Source: Signals of positive selection. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Faroese whole genomes provide insight into ancestry and recent selection

Study design awaiting verification · eLife · 2026

Original publication title

Faroese whole genomes provide insight into ancestry and recent selection

Iman Hamid; Ólavur Mortensen; Alba Refoyo-Martínez; Leivur N Lydersen; Anne-Katrin Emde; Melissa Hendershott; Katrin D Apol; Guðrið Andorsdóttir; Jonas Meisner; Kaja A Wasik; Fernando Racimo; Stephane E Castel; Noomi O Gregersen

© 2025, Hamid, Mortensen, Refoyo-Martínez et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The Faroe Islands are home to descendants of a North Atlantic founder population with a unique history shaped by both migration and periods of relative isolation. Here, we investigate the genetic diversity, population structure, and demographic history of the islands by analyzing whole genome sequencing data from 40 participants in the Faroe Genome Project. This represents the first whole genome sequencing panel of this size from the Faroe Islands. We observed numerous putatively functional private alleles, including stop gain variants and high impact missense variants in the cohort.

Faroese individuals had a higher proportion of their genomes contained in long runs of homozygosity than other European groups, including Finnish, suggesting a more recent or stronger bottleneck in the Faroese population. Signals of positive selection were identified at loci containing genes that play roles in vitamin D and dietary fat absorption and DNA repair, while increased diversity on lactase persistence haplotypes was observed. Fine-scale analysis of haplotype structure in present-day and ancient European genomes revealed genetic affinities with ancient Iron Age individuals from the North and West of Europe, providing evidence for potential contributions to the Faroese gene pool from Celtic and Viking populations as well as information about the temporal order in which these events happened.

This study highlights the impact of evolutionary processes, such as ancient admixture, founder events, and positive selection, on the present-day genetic architecture of North Atlantic founder populations like the Faroe Islands.

eLife digest

Our DNA contains a wealth of information about our ancestors. By examining the DNA of present-day populations, researchers can infer aspects of their history, including migration patterns, interactions with other groups, changes in population size, and adaptation to local environments.

When a small group of “founders” settles a new location, they carry only a subset of the larger population’s genetic diversity. As a result, their descendants often exhibit reduced genetic diversity and elevated frequencies of certain genetic variants, some of which may influence health, disease, or adaptation.

The Faroe Islands, a remote North Atlantic archipelago, were settled around the 9th century CE, primarily by people from Scandinavia and the British Isles. Today’s population of approximately 54,000 Faroese descends from this relatively small founding group. This distinctive demographic history: characterized by mixed ancestry, geographic isolation, and a limited number of founders: is likely reflected in the genomes of present-day Faroese individuals.

To investigate the genetic diversity, ancestry, and evolutionary history of the Faroese population, Hamid et al. conducted whole-genome sequencing on 40 individuals selected to represent the geographic diversity of the islands. Previous studies of the Faroese population were limited either to small sample sizes (fewer than 10 individuals) or to specific regions of the genome, leaving substantial gaps in our understanding of the population’s full genetic landscape. The Faroe Islands also have elevated rates of several diseases, including inflammatory bowel disease and type 2 diabetes, compared with other European populations.

Understanding the unique genetic architecture and demographic history of the Faroese population may therefore provide important insight into the genetic basis of these health disparities.

The analyses revealed that Faroese individuals carry numerous rare and potentially disease-associated genetic variants that are absent from mainland European populations, including variants predicted to disrupt gene function. Compared with other European groups: including Finns, another well-known founder population: Faroese genomes contain longer runs of homozygosity (long, identical DNA segments), reflecting extensive segments of identical DNA inherited from common ancestors. This pattern suggests a stronger or more recent population bottleneck in the Faroese population.

Hamid et al. also identified signatures of natural selection in genes involved in vitamin D metabolism and dietary fat absorption (SLC10A1), as well as DNA repair (POLQ), which may reflect adaptation to the Faroese environment and traditional diet. Comparisons with ancient European genomes indicated that the Faroese derive approximately equal ancestry from Iron Age “West European” (Celtic-related) and “North European” (Viking-related) populations. Importantly, the data suggest that this genetic mixing likely occurred before the settlement of the islands rather than afterwards.

These findings have direct relevance for the Faroese population because they identify genetic variants enriched in the islands that may contribute to conditions such as glycogen storage disease, ankylosing spondylitis, and other disorders. In the future, this knowledge could help inform disease prevention strategies and clinical care in the Faroe Islands. However, the study of Hamid et al. represents only a pilot phase. A greater ongoing effort, the FarGen project, aims to integrate genomic data with detailed health records to better understand the relationship between genetics and disease in the Faroese population.

More broadly, the Faroe Islands provide an important model for studying how historical isolation and founder effects shape genetic diversity and disease risk in human populations worldwide.

Authors’ abstract

The Faroe Islands are home to descendants of a North Atlantic founder population with a unique history shaped by both migration and periods of relative isolation. Here, we investigate the genetic diversity, population structure, and demographic history of the islands by analyzing whole genome sequencing data from 40 participants in the Faroe Genome Project. This represents the first whole genome sequencing panel of this size from the Faroe Islands. We observed numerous putatively functional private alleles, including stop gain variants and high impact missense variants in the cohort.

Faroese individuals had a higher proportion of their genomes contained in long runs of homozygosity than other European groups, including Finnish, suggesting a more recent or stronger bottleneck in the Faroese population. Signals of positive selection were identified at loci containing genes that play roles in vitamin D and dietary fat absorption and DNA repair, while increased diversity on lactase persistence haplotypes was observed. Fine-scale analysis of haplotype structure in present-day and ancient European genomes revealed genetic affinities with ancient Iron Age individuals from the North and West of Europe, providing evidence for potential contributions to the Faroese gene pool from Celtic and Viking populations as well as information about the temporal order in which these events happened.

This study highlights the impact of evolutionary processes, such as ancient admixture, founder events, and positive selection, on the present-day genetic architecture of North Atlantic founder populations like the Faroe Islands.

eLife digest

Our DNA contains a wealth of information about our ancestors. By examining the DNA of present-day populations, researchers can infer aspects of their history, including migration patterns, interactions with other groups, changes in population size, and adaptation to local environments.

When a small group of “founders” settles a new location, they carry only a subset of the larger population’s genetic diversity. As a result, their descendants often exhibit reduced genetic diversity and elevated frequencies of certain genetic variants, some of which may influence health, disease, or adaptation.

The Faroe Islands, a remote North Atlantic archipelago, were settled around the 9th century CE, primarily by people from Scandinavia and the British Isles. Today’s population of approximately 54,000 Faroese descends from this relatively small founding group. This distinctive demographic history: characterized by mixed ancestry, geographic isolation, and a limited number of founders: is likely reflected in the genomes of present-day Faroese individuals.

To investigate the genetic diversity, ancestry, and evolutionary history of the Faroese population, Hamid et al. conducted whole-genome sequencing on 40 individuals selected to represent the geographic diversity of the islands. Previous studies of the Faroese population were limited either to small sample sizes (fewer than 10 individuals) or to specific regions of the genome, leaving substantial gaps in our understanding of the population’s full genetic landscape. The Faroe Islands also have elevated rates of several diseases, including inflammatory bowel disease and type 2 diabetes, compared with other European populations.

Understanding the unique genetic architecture and demographic history of the Faroese population may therefore provide important insight into the genetic basis of these health disparities.

The analyses revealed that Faroese individuals carry numerous rare and potentially disease-associated genetic variants that are absent from mainland European populations, including variants predicted to disrupt gene function. Compared with other European groups: including Finns, another well-known founder population: Faroese genomes contain longer runs of homozygosity (long, identical DNA segments), reflecting extensive segments of identical DNA inherited from common ancestors. This pattern suggests a stronger or more recent population bottleneck in the Faroese population.

Hamid et al. also identified signatures of natural selection in genes involved in vitamin D metabolism and dietary fat absorption (SLC10A1), as well as DNA repair (POLQ), which may reflect adaptation to the Faroese environment and traditional diet. Comparisons with ancient European genomes indicated that the Faroese derive approximately equal ancestry from Iron Age “West European” (Celtic-related) and “North European” (Viking-related) populations. Importantly, the data suggest that this genetic mixing likely occurred before the settlement of the islands rather than afterwards.

These findings have direct relevance for the Faroese population because they identify genetic variants enriched in the islands that may contribute to conditions such as glycogen storage disease, ankylosing spondylitis, and other disorders. In the future, this knowledge could help inform disease prevention strategies and clinical care in the Faroe Islands. However, the study of Hamid et al. represents only a pilot phase. A greater ongoing effort, the FarGen project, aims to integrate genomic data with detailed health records to better understand the relationship between genetics and disease in the Faroese population.

More broadly, the Faroe Islands provide an important model for studying how historical isolation and founder effects shape genetic diversity and disease risk in human populations worldwide.

Publication and source details

Original title: Faroese whole genomes provide insight into ancestry and recent selection

Iman Hamid; Ólavur Mortensen; Alba Refoyo-Martínez; Leivur N Lydersen; Anne-Katrin Emde; Melissa Hendershott; Katrin D Apol; Guðrið Andorsdóttir; Jonas Meisner; Kaja A Wasik; Fernando Racimo; Stephane E Castel; Noomi O Gregersen

eLife · 2026

†

These authors contributed equally to this work.

© 2025, Hamid, Mortensen, Refoyo-Martínez et al2025Hamid, Mortensen, Refoyo-Martínez et alhttps://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. https://ror.org/04txyc737Novo Nordisk Fonden NNF22OC0076816 Racimo Fernando https://ror.org/0472cxd90European Research Council 10.3030/101077592 Racimo Fernando https://ror.org/0472cxd90European Research Council 10.3030/951385 Racimo Fernando The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:18:57.945406+00:00

DOI: 10.7554/elife.107428 · PMC13271744